VesellE. S.PageJ. G.: Genetic Control of the Phenobarbital-Induced Shortening of Plasma Antipyrine Half-Lives in Man. J. Clin. Invest.48: 2202–2209, 1969.
2.
VesellE. S.PassanantiG. T.GreeneF. E.: Impairment of Drug Metabolism in Man by Allopurinol and Nortriptyline. New Eng. J. Med.283: 1484–1488, 1970.
3.
VesellE. S.PassanantiG. T.LeeC. H.: Impairment of Drug Metabolism by Disulfiram in Man. Clin. Pharmacol. Ther.12: 785–792, 1971.
4.
VesellE. S.NgL.PassanantiG. T.ChaseT. N.: Inhibition of Drug Metabolism by Levodopa in Combination with a Dopa-Carboxylase Inhibitor. Lancet2: 370, 1970.
5.
VesellE. S.PageJ. G.PassanantiG. T.: Genetic and Environmental Factors Affecting Ethanol Metabolism in Man. Clin. Pharmacol. Ther.12: 192–201, 1971.
6.
VesellE. S.PassanantiG. T.: Utility of Clinical Chemical Determinations of Drug Concentrations in Biological Fluids. Clin. Chem.17: 851–866, 1971.
7.
VesellE. S.PassanantiG. T.: Differential Effects of Chronic Halofenate Administration on Drug Metabolism in Man. Fed. Proc.31: 538, 1972.
8.
VesellE. S.PassanantiG. T.HainesC. F.: (in preparation).
